- Home
- SXTP vs ADIL Comparison
SXTP vs ADIL Comparison
Compare SXTP & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- ADIL
- Stock Information
- Founded
- SXTP 2010
- ADIL 2010
- Country
- SXTP United States
- ADIL United States
- Employees
- SXTP N/A
- ADIL N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- SXTP Health Care
- ADIL Health Care
- Exchange
- SXTP Nasdaq
- ADIL Nasdaq
- Market Cap
- SXTP 6.7M
- ADIL 7.7M
- IPO Year
- SXTP 2023
- ADIL 2018
- Fundamental
- Price
- SXTP $1.38
- ADIL $0.36
- Analyst Decision
- SXTP Buy
- ADIL Strong Buy
- Analyst Count
- SXTP 2
- ADIL 2
- Target Price
- SXTP $3.00
- ADIL $4.75
- AVG Volume (30 Days)
- SXTP 287.4K
- ADIL 698.3K
- Earning Date
- SXTP 11-14-2025
- ADIL 11-13-2025
- Dividend Yield
- SXTP N/A
- ADIL N/A
- EPS Growth
- SXTP N/A
- ADIL N/A
- EPS
- SXTP N/A
- ADIL N/A
- Revenue
- SXTP $984,494.00
- ADIL N/A
- Revenue This Year
- SXTP $81.41
- ADIL N/A
- Revenue Next Year
- SXTP $83.17
- ADIL N/A
- P/E Ratio
- SXTP N/A
- ADIL N/A
- Revenue Growth
- SXTP 128.70
- ADIL N/A
- 52 Week Low
- SXTP $1.22
- ADIL $0.22
- 52 Week High
- SXTP $12.45
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- SXTP 42.79
- ADIL 45.59
- Support Level
- SXTP $1.43
- ADIL $0.35
- Resistance Level
- SXTP $1.52
- ADIL $0.38
- Average True Range (ATR)
- SXTP 0.11
- ADIL 0.03
- MACD
- SXTP -0.02
- ADIL -0.00
- Stochastic Oscillator
- SXTP 6.12
- ADIL 24.74
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.